Benzoimidazol-2-yl pyridines as modulators of the histamine H4 receptor

Details for Australian Patent Application No. 2007235577 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Edwards, James P.; Kindrachuk, David E.; Venable, Jennifer D.

Agent Shelston IP

Pub. Number AU-B-2007235577

PCT Pub. Number WO2007/117400

Priority 60/788,188 31.03.06 US

Filing date 30 March 2007

Wipo publication date 18 October 2007

Acceptance publication date 15 September 2011

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

30 October 2008 PCT application entered the National Phase

  PCT publication WO2007/117400 Priority application(s): WO2007/117400

15 September 2011 Application Accepted

  Published as AU-B-2007235577

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007235578-Indoles and benzoimidazoles as modulators of the histamine H4 receptor

2007235576-Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor